Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tolley

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|October 9, 1998
Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries. Ghent International Working Group on Mother-to-Child Transmission of HIVM L Newell, F Dabis, K Tolley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Decision-Focused Mixed Treatment Comparison (MTC) of Alternative Dpp-4 Inhibitors (Dpp-4i's) Used in Combination With Metformin or a Sulfonylurea for the Treatment of Type 2 Diabetes Mellitus (T2DM)K Tolley, A Strickson, S Kay, et al.
The American Journal of Physiology|April 1, 1992
Skeletal muscle beta-adrenoceptor distribution and responses to isoproterenol in hyperthyroidismW H Martin, E Korte, T K Tolley, et al.
BMJ (Clinical Research Ed.)|June 17, 1998
Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis modelA E Duggan, K Tolley, C J Hawkey, et al.
Current Medical Research and Opinion|April 29, 2008
Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United KingdomJ Karnon, K Tolley, J Oyee, et al.
Journal of Medical Economics|September 4, 2010
Cost effectiveness of deferasirox compared to desferrioxamine in the treatment of iron overload in lower-risk, transfusion-dependent myelodysplastic syndrome patientsK Tolley, N Oliver, E Miranda, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2013
Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitisS Vegter, K Tolley, T Wilson Waterworth, et al.
The Journal of Physiology|February 4, 2003
Functional analysis of neurotransmission at beta2-laminin deficient terminalsDavid Knight, Lynn K Tolley, David K Kim, et al.
International Journal of Technology Assessment in Health Care|January 1, 1995
Communication aids for the speech impaired. Cost and quality-of-life outcomes of assessment programs provided by specialist Communication Aids Centers in the United KingdomK Tolley, B Leese, K Wright, et al.
Health Trends|December 9, 1992
Evaluation of Communication Aid Centres in England and WalesA Chamberlain, C Rowley, J Stowe, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|October 9, 1998
Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries. Ghent International Working Group on Mother-to-Child Transmission of HIVM L Newell, F Dabis, K Tolley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Decision-Focused Mixed Treatment Comparison (MTC) of Alternative Dpp-4 Inhibitors (Dpp-4i's) Used in Combination With Metformin or a Sulfonylurea for the Treatment of Type 2 Diabetes Mellitus (T2DM)K Tolley, A Strickson, S Kay, et al.
The American Journal of Physiology|April 1, 1992
Skeletal muscle beta-adrenoceptor distribution and responses to isoproterenol in hyperthyroidismW H Martin, E Korte, T K Tolley, et al.
BMJ (Clinical Research Ed.)|June 17, 1998
Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis modelA E Duggan, K Tolley, C J Hawkey, et al.
Current Medical Research and Opinion|April 29, 2008
Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United KingdomJ Karnon, K Tolley, J Oyee, et al.
Journal of Medical Economics|September 4, 2010
Cost effectiveness of deferasirox compared to desferrioxamine in the treatment of iron overload in lower-risk, transfusion-dependent myelodysplastic syndrome patientsK Tolley, N Oliver, E Miranda, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2013
Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitisS Vegter, K Tolley, T Wilson Waterworth, et al.
The Journal of Physiology|February 4, 2003
Functional analysis of neurotransmission at beta2-laminin deficient terminalsDavid Knight, Lynn K Tolley, David K Kim, et al.
International Journal of Technology Assessment in Health Care|January 1, 1995
Communication aids for the speech impaired. Cost and quality-of-life outcomes of assessment programs provided by specialist Communication Aids Centers in the United KingdomK Tolley, B Leese, K Wright, et al.
Health Trends|December 9, 1992
Evaluation of Communication Aid Centres in England and WalesA Chamberlain, C Rowley, J Stowe, et al.
Pageof 6